Further investigation showed that IRF2 upregulated inositol polyphosphate-4-phosphatase, type-II (INPP4B) expression via binding to INPP4B promoter, which in turn inhibited cell apoptosis in AML cells. The gene discussed is INPP4B; the disease is acute myeloid leukemia.